A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis
Author:
- 1 September 2014
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 166, 353-358
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical EndocrinologistsThyroid®, 2011
- Thyroid Functions and Bipolar Affective DisorderJournal of Thyroid Research, 2011
- Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depressionMolecular Psychiatry, 2005
- Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal studyJournal of Affective Disorders, 2004
- Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disordersJournal of Affective Disorders, 2002
- Thyroid Hormone, Neural Tissue and Mood ModulationThe World Journal of Biological Psychiatry, 2001
- Prevalence Of Osteoporosis In Women: Variation With Skeletal Site Of Measurement Of Bone Mineral DensityEndocrine Practice, 2000
- Differences in thyroid function between bipolar manic and mixed statesBiological Psychiatry, 1998
- Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorderPsychiatry Research, 1990
- Rapid Cycling Bipolar Affective DisorderArchives of General Psychiatry, 1990